Details for New Drug Application (NDA): 091431
✉ Email this page to a colleague
The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.
Summary for 091431
| Tradename: | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE |
| Applicant: | Heritage |
| Ingredient: | amlodipine besylate; benazepril hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 091431
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors Calcium Channel Antagonists Cytochrome P450 3A Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
Suppliers and Packaging for NDA: 091431
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | amlodipine besylate; benazepril hydrochloride | CAPSULE;ORAL | 091431 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-925 | 23155-925-01 | 100 CAPSULE in 1 BOTTLE (23155-925-01) |
| AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | amlodipine besylate; benazepril hydrochloride | CAPSULE;ORAL | 091431 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-925 | 23155-925-05 | 500 CAPSULE in 1 BOTTLE (23155-925-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 2.5MG BASE;10MG | ||||
| Approval Date: | Dec 30, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE;10MG | ||||
| Approval Date: | Dec 30, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE;20MG | ||||
| Approval Date: | Dec 30, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
